Geoffrey Mackay Avrobio, Inc. (AVRO) insider trading activity

AVRO Quotes by TradingView

Geoffrey Mackay is President & CEO of AVROBIO, Inc.. Currently has a direct ownership of 188,012 shares of AVRO, which is worth approximately $0. The most recent transaction as insider was on Jan 24, 2023, when has been sold 45,999 shares (Common Stock) at a price of $0.91 per share, resulting in proceeds of $41,859. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 188K
0% 3M change
0% 12M change
Total Value Held $0

GEOFFREY MACKAY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 24 2023
BUY
Exercise of conversion of derivative security
$41,859 $0.91 p/Share
45,999 Added 19.66%
188,012 Common Stock
Dec 28 2022
SELL
Bona fide gift
-
245,123 Reduced 63.32%
142,013 Common Stock
Dec 23 2022
BUY
Exercise of conversion of derivative security
$58,225 $0.41 p/Share
142,013 Added 26.84%
387,136 Common Stock
Dec 24 2020
BUY
Exercise of conversion of derivative security
$41,000 $0.41 p/Share
100,000 Added 28.98%
245,123 Common Stock

Also insider at

TALS
Talaris Therapeutics, Inc. Healthcare
Director
GM

Geoffrey Mackay

President & CEO
Cambridge, MA

Track Institutional and Insider Activities on AVRO

Follow AVROBIO, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVRO shares.

Notify only if

Insider Trading

Get notified when an Avrobio, Inc. insider buys or sells AVRO shares.

Notify only if

News

Receive news related to AVROBIO, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AVRO